Epithelial ovarian cancer with CD117 phenotype is highly aggressive and resistant to chemotherapy

The Src and c-Kit kinase inhibitor dasatinib enhances p53-mediated targeting of human acute myeloid leukemia stem cells by chemotherapeutic agents

(2013) C. Dos Santos et al.   BLOOD

CD117 expression in operable oesophageal squamous cell carcinomas predicts worse clinical outcome

(2013) Huijie Fan et al.   HISTOPATHOLOGY

Small gastrointestinal stromal tumor in the stomach: identification of precursor for clinical gastrointestinal stromal tumor using c-kit and α-smooth muscle actin expression

(2013) Tetuo Mikami et al.   HUMAN PATHOLOGY

Phosphorylation of the Activation Loop Tyrosine 823 in c-Kit Is Crucial for Cell Survival and Proliferation

(2013) Shruti Agarwal et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Cyclic AMP and c-KIT Signaling in Familial Testicular Germ Cell Tumor Predisposition

(2013) Monalisa F. Azevedo et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

The prognostic impact of c-KIT mutation in systemic mastocytosis associated with acute myeloid leukaemia patients

(2013) Dahae Won et al.   LEUKEMIA RESEARCH

Immunohistochemistry with apoptotic-antiapoptotic proteins (p53, p21, bax, bcl-2), c-kit, telomerase, and metallothionein as a diagnostic aid in benign, borderline, and malignant serous and mucinous ovarian tumors

(2012) Hatice Ozer et al.   Diagnostic Pathology

KIT (CD117) Expression in a Subset of Non-Small Cell Lung Carcinoma (NSCLC) Patients

(2012) Albert D. Donnenberg et al.   PLoS One

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Ovarian cancer cells with the CD117 phenotype are highly tumorigenic and are related to chemotherapy outcome

(2011) Lijing Luo et al.   EXPERIMENTAL AND MOLECULAR PATHOLOGY

c-kit (CD117) Expression in Human Tumors and its Prognostic Value: An Immunohistochemical Analysis

(2010) Michael Medinger et al.   PATHOLOGY & ONCOLOGY RESEARCH

Cancer Stem Cells and Aneuploid Populations within Developing Tumors Are the Major Determinants of Tumor Dormancy

(2009) A. P. Kusumbe et al.   CANCER RESEARCH

The Side Population of Ovarian Cancer Cells Is a Primary Target of IFN-  Antitumor Effects

(2008) L. Moserle et al.   CANCER RESEARCH

Identification and Characterization of Ovarian Cancer-Initiating Cells from Primary Human Tumors

(2008) S. Zhang et al.   CANCER RESEARCH

Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells

(2008) T Baba et al.   ONCOGENE